[
    [
        {
            "time": "",
            "original_text": "[推荐评级] 上海医药(601607)深度研究：国务院发布仿制药政策意见 加快进口替代利好上海医药",
            "features": {
                "keywords": [
                    "上海医药",
                    "仿制药",
                    "政策意见",
                    "进口替代",
                    "利好"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级] 上海医药(601607)深度研究：国务院发布仿制药政策意见 加快进口替代利好上海医药",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[增持评级] 医药生物行业周报：市场调整是医药板块逐步布局的好时机",
            "features": {
                "keywords": [
                    "医药生物",
                    "市场调整",
                    "布局",
                    "好时机"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 医药生物行业周报：市场调整是医药板块逐步布局的好时机",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级] 药交会思考系列(一)：新时代背景下医药零售的变革",
            "features": {
                "keywords": [
                    "药交会",
                    "医药零售",
                    "变革",
                    "新时代"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强于大市评级] 药交会思考系列(一)：新时代背景下医药零售的变革",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]